Report
Aurelien Sivignon

Prodways Group : Towards a gradual recovery in profitability but still no inflection in the short-term growth trajectory

>Difficult H1 2024 results as expected - For sales (already published) of € 31.1m, down 28% y-o-y (-4% on a like-for-like basis), underlying EBITDA fell by 47% to € 2.5m (vs € 2.7m est), giving a margin of 8% (-3 pts y-o-y), although reflecting a sequential improvement (+4 pts vs H2 2023) as a result of the various measures taken in recent months (shutdown of the Solidscape business, disposal of Cristal), which led to a reduction in the workforce of around 100 people....
Underlying
Prodways Group SA

Prodways Group SA. Prodways Group SA is a France-based company engaged in the industrial machinery sector. The Company focuses its activities on the industrial three-dimensional (3D) printing market and more specifically on ''rapid manufacturing'' 3D printing for industrial series production. The Company designs, manufactures and sells products for various industries, including automotive, dental, molding, medical, jewelry and luxury, aerospace and defense, architectural and design, consumer products and academic and research. It offers its customers multi-technology, multi-application industrial solutions, 3D printing systems and a wide range of composite, hybrid and powder products. In addition, it also develops its own manufacturing for the podiatry (orthopaedic soles) and dentistry (orthodontic pieces and dental trays) markets that is sold directly to healthcare professionals. It operates through Avenao Industrie and Interson-Protac.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Aurelien Sivignon

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch